[Treatment of malignant low-grade lymphoma. Follicular Lymphoma Study Group].
Solal-Celigny
P
P
Centre Jean-Bernard, clinique Victor-Hugo, Le Mans, France.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018951:Antigens, CD20 / Q000276:immunology; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D008224:Lymphoma, Follicular / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D016499:Radioimmunotherapy
D000911:Antibodies, Monoclonal; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D016898:Interferon-alpha